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ABSTRACT 
 Aim: To evaluate early bone loss around three different implant systems 
(Straumann Bone Level. Noble Biocare Replace, 3i Biomet Certain) and compare them to 
each other in a prospective clinical study using clinical and radiographic measurements. 
Material and Methods: Twenty-three patients were recruited for the study. Three 
implant systems were included in study design; one system was abandoned due to lack of 
subjects. Two implant systems (Nobel Biocare Replace n= 12, Straumann Bone Level n= 
11) were evaluated. Periodontic residents placed the implants.  Radiographic and clinical 
measurements were obtained at two different time points, at the time of implant 
placement and at the time of second stage surgery. 
Results: Mean clinical bone loss was 0.14 ± 0.20 mm, and 0.72 ± 1.02 mm for 
Straumann and Nobel Biocare respectively. The mean change in the radiographic bone 
loss for Straumann and Nobel Biocare was 0.23 ± 0.26 mm and 0.53 ± 1.06 mm.  There 
was no statistically significant difference between the two groups.   
Conclusion: Nobel Biocare Replace tapered implants showed a two and five times higher 
average bone loss in radiographic and clinical parameters respectively, compared to 
Straumann implants. However, this difference did not reach statistical significance in 
		 vi 
either the clinical or the radiographic measurement. It is suggested that study size should 
be increased.	 																																							
		 vii 
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INTRODUCTION 
Advances in research and technology in dental implants have made both replacement of 
single missing teeth with endosseous implants and implant supported prostheses the treatments 
of choice for rehabilitation (Baqain, Moqbel et al. 2012). The osseointegration process provides a 
sturdy connection between the mineral compartment of the bone and the Ti oxide layer of the 
various grades of implant titanium by ingrowth of osteoblasts and the deposition of calcified 
matrix (Terheyden, Lang et al. 2012, Terheyden, Stadlinger et al. 2014, Cassetta, Pranno et al. 
2015, van Eekeren, Tahmaseb et al. 2015).  The issue of bone stability during the integration 
process and over time is still a question of great importance. In a retrospective review of three 
different implant systems (Nobel Biocare Replace, Straumann Bone Level, 3i Biomet Osseotite) 
bone loss of 10%, 5%, 4%, respectively was found at time of 2nd stage uncovering (Alrowis R 
2016). Albrektsson and colleagues established early (1981) criteria for the evaluation of a 
successful implant. However, their measurements focused on the biological integration and 
mechanical stability of a specific implant design (the Branemark hex platform implant) that was 
the prototype for modern implant design (Albrektsson, Branemark et al. 1981). 
 This prototype and the technical procedures for its use were first presented by the team of 
PI Branemark, Tomas Albrektsson, and George Zarb (Brånemark 1985).  The Branemark 
“fixture” has a cylindrical geometry with a core body diameter of 3.0 mm and a tapered apical 
end (Figure 1). The body core has external threads which extends its diameter to 3.75 or 4.0mm. 
A flared taper at the coronal portion expands this core to a restorative platform diameter of 4.1 
mm. The restorative platform is a flat circular table with an internal screw chamber in the center 
surrounded by an elevated hex nut. The hex nut is 0.7 mm in height and is used to drive the 
implant into place. After implant placement the screw chamber of the hex extension is sealed 
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with a cover screw which extends the final length by 1.0-mm. Prior to osteotomy and placement 
the bone surface is accessed by reflecting a full thickness flap. The osteotomy preparation is 
completed with a countersink in its most coronal aspect to accommodate the flared head of the 
implant design and leave the cover screw surface flush with the surrounding bone surface. The 
tension created between the flared head of the implant as it encounters the countersink feature of 
the osteotomy and the drive of the screw threads pulling the implant into the bone creates an 
initial mechanical stability for the implant. When the placement is complete the implant is then 
covered by the flap and allowed to heal for 3-6 months prior to exposure. At the 2nd stage or 
abutment phase surgery a simple “trap door” incision is made over the implant which allows 
removal of the cover screw and attachment of an abutment via the internal screw chamber. This 
abutment extends the fixture through the soft tissue and allows later access for attachment of 
whatever prosthesis is desired. Since the abutment flares from 4.1mm at its interface with the 
restorative platform to 5.0 mm diameter within the first mm of its length the circumference of 
bone around the hex platform (which we noted is 1.0mm below the bone surface) is immediately 
subjected to compression and later to physical manipulations and pressures of the restorative 
phase. Within the first year a remodeling of this marginal bone, is typically seen as a cup shape 
defect in postoperative periapical radiographs.  
 Changes in design and protocol over the last 30 years have targeted this 
bone/abutment/implant interface in an attempt to influence the bones reaction to it. The sequence 
of placement, restorative steps, and final restoration provides three separate intervals for study: 
1. The interval from implant insertion to abutment connection 
  2. The time from abutment connection to final prosthesis 
  3. The time after loading pressures from the final prosthesis. 
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Alrowis’s earlier retrospective report work suggested that there was no significant difference in 
bone loss occurring at the earliest interval before the abutment connection (Alrowis et al 2016). 
The current research project sought to design a prospective analysis with a controlled systematic 
approach in an attempt to verify theses findings.  The 3 different systems utilized in our clinic 
represent 3 variations in implant abutment interface and its relationship to crestal bone. The 
Biomet 3i is closest to the original Branemark model with the implant abutment interface 1 mm 
below the bone level.  The Noble Replace has an internal connection but maintains the 
implant/abutment interface at the bone margin. The ITI Straumann, in contrast, because of it’s 
internal cone attachment geometry separates the implant /abutment interface from the 
implant/bone interface by the creation of  a small ledge at the bone, which affects an interface 
relationship sometimes referred to as “platform switch”. This results in a soft tissue interface at 
the implant/abutment connection.   
The 3i implant studied in this analysis was the Biomet 3i Osseotite which is a clone of the 
Branemark design and commonly displays up to 1 mm of average bone loss during the first year 
after placement. This implant system showed a steady state with respect to further bone loss after 
the first year. There were no significant differences in bone loss between the different implant 
systems evaluated in this review between the 1 and 5 year follow-up (Jimbo and Albrektsson 
2015). In contrast, the internal attachment implant Nobel Replace Select showed average crestal 
bone loss of 0.9 ± 1.6 mm after 1 year and 0.1 mm ± 2.4 after 5 years (Pettersson and Sennerby 
2015).  Bone loss for Straumann Bone Level implants can reach 0.4 ± 0.1 mm in the first 
postoperative year(Markovic, Colic et al. 2015). Other studies have shown bone loss of 1.5 mm 
in the first year. Per Astrand et al demonstrated an initial difference between Astra implants (an 
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internal cone attachment like the Straumann) and Branemark hex top implants in the early 
healing period (Astrand, Engquist et al. 1999)but on follow-up after five years they found no 
significant difference (Astrand, Engquist et al. 2004). Another study comparing Straumann bone 
level dental implants with Branemark for three years found no significant difference in marginal 
bone loss between these systems. The only difference in the early healing stage was in bone 
remodeling (Astrand, Engquist et al. 2004). To our knowledge there have been no clinical studies 
on the early bone loss before the 2nd stage surgery in Nobel Replace implants.  
 
Many studies have evaluated bone loss after one year functional loading. The mean bone loss for 
Branemark Hex platform implants after loading was 1.5 mm for the first year and followed by 
mean bone loss of 0.1 mm/year (Adell, Lekholm et al. 1981). Albrektsson et al showed that up to 
2 mm of marginal bone loss around the implant neck during the first year after functional loading 
is considered as implant success with Branemark implants. They also reported that bone stability 
was established one year after placement and did not exceed 0.2 mm per year thereafter 
(Albrektsson, Zarb et al. 1986). The accepted pattern of loss was a cupping pattern seen on 
peripical radiographs. In 3i Biomet NanoTite implants (another Branemark clone) mean marginal 
bone resorption was 1.01 mm (SD 0.85) during the first year after functional loading in 42 
patients (Ostman, Wennerberg et al. 2013). On the other hand, Papaspyridakos et al in a 
systematic review noted that up to 1.5 mm marginal bone loss in the first year is acceptable 
among many systems (Papaspyridakos, Chen et al. 2012). Another study suggested that up to 
1.5-2 mm bone loss is normal and a good outcome but did not specify the system (Tarnow, Cho 
et al. 2000). Marginal bone loss of less than three threads has also been proposed as a success 
criteria even though there are many different implant systems with varied inter-thread distance 
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and distance from top of implant to first thread (Fransson, Lekholm et al. 2005). Implants with 
increased marginal bone loss at early stages were more likely to reach marginal bone loss values 
that might compromise their long-term outcome(Galindo-Moreno, Leon-Cano et al. 2014, 
Galindo-Moreno, Leon-Cano et al. 2015)  
Implant success was defined by Albrektsson as: “an individual unattached implant that is 
immobile when tested clinically, radiography that does not demonstrate evidence of peri-implant 
radiolucency, bone loss less than 0.2 mm annually after the implant′s first year of service, no 
persistent pain, discomfort or infection”. By these criteria, a success rate of 85% at the end of a 
5-year observation period and 80% at the end of a 10-year period are minimum levels for 
success. (Lekholm, Gunne et al. 1999, Noack, Willer et al. 1999, Ferrigno, Laureti et al. 2002). 
Implant success criteria have been further modified to include esthetic considerations and soft 
tissue management after implant placement. Numerous other studies have reported a general 
success rate of more than 90% for dental implant treatments with no notation of the system used.  
With expanded utilization there has been an increase in failure and complication rates.  
The complications mainly fall into two classifications: 
1.  After fixture placement or surgery-related problems, and this includes bone loss, 
infection, and violation of anatomical structure, improper angulation, and peri-implantitis 
2. After loading or prosthetic problems and this includes: retention screw loosening, screw 
fracture, porcelain fracture, abutment loosening, and prosthetic debonding.  
For both classifications the degree of bone loss was the effect measured. 
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The volume of bone around implants plays a significant role in initial stability. For this reason, 
marginal bone loss is a critical factor in implant success. Many studies have shown that marginal 
bone loss varies with the distance between implants, surgical placement techniques and implant 
surfaces. The difference in marginal bone loss between different implant systems has been 
studied. However, few studies agree on acceptable bone loss. Marginal bone loss originates from 
a combination of mechanical and biological factors. Many factors have been proposed to explain 
this problem including surgical trauma, peri-implant micro-gap, biological width and implant 
crest module (Oh, Yoon et al. 2002).  Herman et al 2001 concluded that the degree of 
inflammation in peri-implant tissues is less around one-piece implants which do not require a 2nd 
stage surgery compared to two-piece implants. Manipulating the soft tissue around the implant 
by repetitive removing and replacing the abutment during prosthetic procedures played a 
significant rule in bone loss around implants (I. Abrahamsson et al 1997). Some bone remodeling 
may be linked to a healing response characterized by a tendency to recover or establish an 
implant version of biological width similar to a natural tooth/soft tissue relationship. (Cochran 
and Nevins 2012). The “Implant crest module” concept includes implant surface texture, implant 
abutment/interface in bone level implants and location of the junction of the rough and smooth 
surfaces.  .  Marginal bone loss after 2nd stage surgery can start as mucositis and progress to peri-
implantitis (Mombelli and Lang 1994). Bone loss in two-stage implants takes place after 
abutment connection.  Factors involved in this type of implant include surgical complications, a 
less-than-ideal initial fit between the implant and the surrounding bone, insufficient pre-surgical 
bone surrounding the implant, and premature loading with resulting micro-movement of the 
implant prior to integration. Healing impairment may result from overall poor systemic health or 
patient oral habits including tobacco product abuse (Toljanic, Banakis et al. 1999, Oh, Yoon et 
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al. 2002) 
There are a number of factors possibly related to loss of marginal bone after placement of 
implants. Variables ranging from implant design features to issues of bone physiology and/or 
wound healing have been explored.  
 
Different implant designs and surfaces:  
The platform switch concept when applied to external attachment systems can be a variable to 
consider. External hexagon attachments (EH) and morse-taper internal cone (MT) connections 
showed statistically significant differences in marginal bone remodeling from baseline to 1 
month follow-up for both MT (p= 0.001) and EH (p <0.001). No additional marginal bone loss 
occurred for MT (p = 0.302) comparing 1 month and 1 year follow-ups, while EH still presented 
crestal bone loss (p = 0.014) when the same follow-up periods were compared (Pessoa, Sousa et 
al. 2016). Comparison of moderately rough and smooth surfaces showed no difference in clinical 
outcome if placed under standard conditions 
 
 
Physiologic Bone remodeling  
Bone remodeling is a complex process by which old bone is continuously replaced by new tissue 
and requires interaction between different cell phenotypes. It is regulated by a variety of 
biochemical and mechanical factors allowing the maintenance of the shape, quality, and size of 
the skeleton (Ducy et al., 1996). This process is performed by clusters of bone-resorbing 
osteoclasts and bone-forming osteoblasts arranged within temporary anatomical structures 
known as “basic multicellular units” (BMUs). This unique structure and arrangement of cells 
within the BMU is critical to bone remodeling ensuring coordination of the sequential phases of 
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this process: activation, resorption, reversal, formation, and termination (Raggatt and Partridge 
2010). In a remodeling cycle within an active BMU, osteoclasts act as the leading cells starting 
bone resorption. This is followed by reversal cells of unclear phenotype which consequently 
cover the newly exposed bone surface. These cells presumably prepare the surface for new 
osteoblasts to begin bone formation and provide signals for osteoblast differentiation and 
migration in a reversal phase. Osteoblasts in the formation phase occupy the last part of the 
BMU remodeling cycle by secreting and depositing non collagenous proteins which form the 
“cement” or “reversal” lines, then depositing the un-mineralized bone matrix known as osteoid 
and help finally in monitoring its formation and mineralization into mature lamellar bone. 
(Raggatt & Partridge, 2010b) When this mature phase is complete, the surface is covered with 
flattened lining cells and a prolonged resting period begins until a new remodeling cycle is 
initiated.  
The stages of the remodeling cycle have different lengths. In human beings resorption 
continues for about 4 or 5 weeks, while formation can continue for 4 months until the new bone 
structural unit is completed (Teitelbaum, 2000). Various stimuli affect bone turnover including 
hormones, cytokines, and mechanical stimuli. The hypothesis that bone remodeling is induced by 
mechanical stimulation was first suggested by Wolf and is generally accepted as the basis of 
various mathematical models for predicting bone morphology and density (Wolff J 1986, J. 
1986:). Two well-known remodeling theories introduced by Carter et al and Huiskes et al were 
incorporated into finite element models (FEMs) to mathematically model the bone density 
distribution in the proximal femur(Carter, Fyhrie et al. 1987, Huiskes, Weinans et al. 1987). 
Bone remodeling theory distinguishes between external remodeling where bone is added or 
removed at the periosteal and endosteal surfaces resulting in changes of shape, and internal 
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remodeling which is characterized by changes in bone density. In one study of implant therapy 
the minerlized tissue occupied by bone multicellular units (BMU) was substantially larger in the 
group with buccal bone defects than in the group without any bone defects  (test 6%, control 
2%)(Carmagnola, Araujo et al. 1999). BMUs are viewed as indicators of bone remodeling 
activity (Buckwalter 1995) and the findings in the previous study demonstrated that even after 7 
months of healing, the process of remodeling was much more active in the defect regions than in 
the control regions with no bone defect. 
 
Systemic Influence on the Regulation of Bone Remodeling 
Hormones such as estrogens and androgens are the most important regulators of bone 
remodeling. Estrogen inhibits bone remodeling by concurrently suppressing osteoblastogenesis 
and osteoclastogenesis from marrow precursors. Both estrogen and androgens inhibit bone 
resorption via effects on the receptor activator of NF-kappaB ligand 
(RANKL)/RANK/osteoprotegerin system as well as by reducing the production of a number of 
pro-resorptive cytokines, along with direct effects on osteoclast activity and lifespan. The 
majority of postmenopausal women show a marked decrease in bone mineral density and high-
turnover bone metabolism. This phenomenon leads to postmenopausal osteoporosis and may 
result in male/female differences in resoponse to surgical trauma. 
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Wound Healing and Surgical Trauma  
 
 
Healing after Tooth Extraction 
 
Bone resorption follows tooth extraction(Johnson 1969, Schropp, Wenzel et al. 2003, Araujo and 
Lindhe 2005). The highest rate of bone resorption occurs during the first 3 months (Johnson, 
1969). A fifty percent reduction in bone width after 12 months was first reported in a human 
study by Schropp et al. in 2003(Schropp, Wenzel et al. 2003). More bone resorption was found 
in buccal bone than lingual bone and more in the horizontal than in the vertical 
dimension(Pietrokovski and Massler 1967, Schropp, Wenzel et al. 2003, Araujo and Lindhe 
2005). Volumetric analysis in beagle dogs demonstrated that the surgical trauma associated with 
flap elevation/vertical releasing incision/suturing during extraction resulted in a significantly 
greater bucco-lingual bone shrinkage than one without flap elevation(Fickl et al., 2008). Buccal 
plate thickness is another factor influencing vertical bone loss. After extraction if the buccal plate 
is thick (>1 mm) there will be about 1.3 mm vertical bone loss compared to 2.3 mm bone loss 
increase thin bone (<1 mm). A minimally traumatic extraction should be always considered for 
ridge preservation. During the 4-8 week period after extraction there was proliferation of 
osteogenic cells and fibroblasts and initiation of immature bone formation on these fibrous 
connective tissues. After 8 weeks, osteogenesis decreased and there was an increase of new 
trabeculae maturation. In the period between 8-12 weeks well-formed trabeculae were present 
with less osteoid and a reduced number of osteoblasts suggesting this is the optimal time for a 
healing socket material to be used for an autogenous graft  (Evian, Rosenberg et al. 1982).  
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Bone Remolding after Implant Placement: 
 
Bone changes occur in three phases after implant placement: healing, remodeling, and 
equilibrium. The remodeling phase is initiated by the altered pattern of force transmission to the 
bone tissue. To withstand the applied functional load, a continuous remodeling allows the bone 
to reach a “steady state.” Mechanical stimulus is the primary bone modifier influenced by other 
in situ variables such as hormonal, metabolic, and genetic factors (Cowin 1993). In a patient with 
a dental implant bone metabolism is affected by a foreign body reaction (non-self/not part of the 
body) which induces strains and stresses on the surrounding bone during functional loading. This 
is very different from a tooth (self/part of the body), which is part of the genetically determined 
and highly specialized dentogingival complex that mediates the transmission of loads through the 
tooth attachment to the alveolar bone. An understanding of the fundamental difference between 
the histology of implant and tooth attachment is of utmost importance when considering the 
related tissue responses(Albrektsson, Chrcanovic et al. 2017). Arajo and Lindhe (2005) used 
histology to determine the dimensional alterations that occurred in bone following placement of 
implants in fresh extraction sockets in beagle dogs (Araujo and Lindhe 2005). Buccal and lingual 
full‐thickness flaps were elevated in both quadrants of the mandible. The distal roots of the third 
and fourth premolars were removed. In the lower right jaw quadrants, Straumann implants with a 
rough surface were placed in the sockets so that the marginal border of the rough surface was 
below the buccal and lingual bone margin. In the lower left jaws, the sockets were left without 
implantation. After 3 months, the soft tissue at the experimental sites in the lower right and left 
jaw quadrants appeared to be properly healed. Histologic sections from the lower lift (socket 
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only) showed the newly formed bone covered the entrance of the socket. The lamellar bone of 
the buccal cortical plate was located about 2.2 mm apical to its lingual counterpart.  By 
comparison, in the lower right (socket +implant), the buccal margin was located about 2.4 mm 
apical to the lingual crest. It was concluded that the placement of an implant in the fresh 
extraction socket did not preserve the cortical plate level which existed before the extraction. 
After 3 months of healing the amount of reduction of the height of the buccal bone wall in 
comparison to the lingual bone alteration was similar at both the implant sites and the edentulous 
sites. At 3 months, the vertical discrepancy between the buccal and lingual bone margins was >2 
mm in both categories.  
 
 
 
 
Most published studies have evaluated bone loss after prosthetic loading. In the present study 
utilizing different implant systems and surfaces, we studied bone loss occurring between the time 
of the implant placement up to the time of 2nd stage or abutment surgery. Three implant systems 
(Noble Biocare Replace, Straumann Bone Level , 3i Biomet Osseotite implants) were compared 
to explore this phenomenon. 
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Figure 1: Diagram showing first generation of Branemark implant (The hex platform). 
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METHODS 
 Study Population: 
The study population was drawn from patients who received dental implants in the 
Periodontology Department at Henry M Goldman School of Dental Medicine.  A sample 
size of thirty-three subjects was the initial estimate considered sufficient (11 for each 
implant system). The study was approved by the Institutional Review Board (IRB) at 
Boston Medical Center, Boston, MA, USA). Three systems were used in this study, 
including Nobel Biocare Replace, Straumann Bone Level and 3i Biomet Osseotite. 
(During the study the use of 3i Biomet was limited by the school and this category was 
excluded from the study.) Patient screening was done through the primary investigator. 
Twenty-two consecutive patients who had implant therapy were selected from the 
surgical schedule of the department implant list based on type of implant system needed. 
The patients of both genders were medically healthy and between age of 18 and 84 years. 
Exclusion criteria included: smoking, diabetes mellitus, osteoporosis, self-reported 
pregnancy, active periodontal disease, simultaneous bone grafting and poor oral hygiene. 
Implants were placed after complete healing of the extraction site and excluded 
immediate implant placement.  All patients were informed about the study design and 
signed an appropriate consent form.  
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Surgical Procedure: 
 To enable advanced planning of implant position, a cone-beam scan (Gallileos; Sirona 
GmbH, Bensheim, Germany) of the initial condition with the implant-drilling template 
inserted were acquired for all patients. Implants were placed by periodontal residents 
under supervision of a faculty periodontist. Under local anesthesia, crestal incision was 
made and a full thickness flap was reflected. An implant drilling sequence using the 
recommended guideline for each system was used.  
Clinical and Radiographic Measurement: 
After implant placement, both clinical and radiographic measurements were made from 
the coronal margin of the implant collar to the adjacent margins of bone.  Clinical, 
periodontal probe measurements were made at four sites around the perimeter of the 
implant: buccal, mesial, distal, lingual (William periodontal probe, Hu-Friedy Mfg, Co., 
LLC, Chicago, IL) (Figure 2, p17). Clinical measures were made from the top edge of the 
implant collar (Fig. 4, 5 p29, 30) Digital periapical radiographs were taken for each 
implant using long cone technique with XCP (XCP Instruments, Rinn Corporation Elgin, 
IL, USA) augmented with an elastomeric impression index incorporated into an 
individualized reusable bite block (Figure 3, p18). Radiographic examination consisted of 
measuring linear distance from the first visible bone to the top of implant collar on both 
mesial and distal side of the radiograph with help of MiPACS system (Charlotte, NC, 
USA). These measurements were repeated at the 2nd stage or abutment surgery 3-6 
months later (Fig 6-7 p31 and Fig 8-9 p32). Both radiographic and clinical measurements 
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were done by a single examiner. 
 
Statistical Analysis  
 
Data was analyzed using SPSS Mac book pro version 21.0 statistical software. 
Descriptive statistics (frequencies, medians, means & standard deviations) were 
calculated. The means of the four clinical readings and the means of the two radiographic 
measures were used for comparison for each implant. Further analysis of the data utilized 
an independent t-test to compare the means of the outcome variables between the two 
systems. A p-value of < 0.05 indicated statistical significance of the results. 
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Figure 2: Clinical bone level at the implant at time of placement “ Nobel Biocare 
Replace implant” approximately 2mm from implant collar margin. 
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Figure 3: XCP used with elastomeric impression material for reproducible peri-apical 
digital radiograph acquisition. 
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RESULTS 
Implant Buccal (mm) Mesial (mm) Lingual (mm) Distal (mm) 
1 0 0 0 0 
2 0 0 0 0 
3 1 0 0 0 
4 1 0 0 0 
5 1 0 0 0 
6 1 1 0 0 
7 1 1 1 1 
8 0 0 0 0 
9 1 0.5 0 0 
10 1 0 0 0 
11 1 2 0 0 
 
Table 1: Clinical bone level relative to implant collar margin at time of placement for 
Straumann Bone Level implants at the buccal, mesial, distal and lingual sites. 
 
Implant Buccal (mm) Mesial (mm) Lingual (mm) Distal (mm) 
1 0 0 0 0 
2 Failed Failed Failed  Failed 
3 1 0 0 0 
4 1 0 1 0 
5 1 0 0 0 
6 1.5 1 1 0 
7 Failed Failed Failed Failed 
8 0 0 0 0 
9 Failed  Failed Failed Failed 
10 1 0 0 0 
11 2 1 1 1 
 
Table 2: Clinical bone level relative to implant collar margin at time of 2nd stage surgery 
for Straumann Bone Level implants at the buccal, mesial, distal and lingual sites.  
 
* Implant failed during the healing process. 
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Implant Buccal (mm) Mesial (mm) Lingual (mm) Distal (mm) 
1 1 1 1 1 
2 1 2 1 1 
3 2 1 1 0 
4 0 0 0 0 
5 0 0 0 0 
6 1 0 0 0 
7 1 1 0 0 
8 1 1 0 1 
9 1 1 0 0 
10 1 0 0 0 
11 1 0 1 0 
12 1 1 1 1 
 
Table 3: Clinical bone level relative to implant collar margin at time of placement for 
Nobel Biocare Replace implants at the buccal, mesial, distal and lingual sites. 
 
Implant Buccal (mm) Mesial (mm) Lingual (mm) Distal (mm) 
1 2 1 2 1 
2 Failed Failed Failed Failed 
3 2 1 1 0 
4 3 2 3 2 
5 0 0 0 0 
6 3 3 4 2 
7 2 1 1 2 
8 Failed* Failed Failed Failed 
9 1 0 0 0 
10 1 0 0 1 
11 1 0 1 0 
12 2 1 1 1 
 
Table 4: Clinical bone level relative to implant collar margin at time of 2nd stage surgery 
for Nobel Biocare Replace implants at the buccal, mesial, distal and lingual sites. 
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Implant Mesial (mm) Distal (mm) 
1 0 0 
2 0 0 
3 0.25 0.25 
4 0 0 
5 0 0 
6 0 0 
7 0 F 
8 0 0 
9 0 F 
10 1 1 
11 0.2 0.6 
 
Table 5: Radiographic bone level at time of placement for Straumann Bone Level 
implants at the mesial and distal sites using MiPACS system. 
 
 
Implant Mesial (mm) Distal (mm) 
1 0 0 
2 Failed Failed 
3 0.6 0.4 
4 0 0 
5 0 0 
6 0.7 0.3 
7 Failed Failed 
8 0 0 
9 Failed Failed 
10 1 1 
11 0.4 0.45 
 
Table 6: Radiographic bone level at time of 2nd stage surgery for Straumann Bone Level 
implants at the mesial and distal sites using MiPACS system. 
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Implant Mesial (mm) Distal (mm) 
1 1.1 0.9 
2 0 0.5 
3 0 0 
4 0 0 
5 0 0 
6 1 1 
7 0.70 0.80 
8 0 0 
9 0 0 
10 0.45 0.55 
11 0 0 
12 1 1 
 
Table 7: Radiographic bone level at time of placement for Nobel Biocare Replace 
implants at the mesial and distal sites using MiPACS system. 
 
Implant Mesial (mm) Distal (mm) 
1 1.5 1 
2 Failed Failed 
3 0 0 
4 1.8 2.2 
5 0 0 
6 4 4 
7 0.77 0.83 
8 Failed Failed 
9 0 0 
10 0.45 0.55 
11 0 0 
12 1 1 
 
Table 8: Radiographic bone level at time of 2nd stage surgery for Nobel Biocare Replace 
implants at the mesial and distal sites using MiPACS system. 
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Mean Age  
 
56 ± 16.1 Years 
(Straumann: 56 ± 18.9 Years) 
(Nobel Biocare : 51.9 ± 14 Years) 
Gender (%) 
   Female 
 
    
   
 Male 
 
61%   
(Straumann: 27.8%, Nobel Biocare 
33.3%) 
 
39%  
(Straumann: 16.7 %, Nobel Biocare 
22.2%) 
Mean clinical bone level from the implant collar 
to the bone at the time of the implant placement  
     Straumann 
     Nobel Biocare 
 
 
0.25 ± 0.23 mm 
0.55 ± 0.41 mm  
Mean clinical bone level from the implant collar 
to the bone at the time of the 2nd stage surgery 
     Straumann 
     Nobel Biocare 
 
 
0.53 ± 0.4 mm  
1.2 ± 0.5 mm 
Mean radiographic bone level from the implant 
collar to the bone at the time of the implant 
placement 
     Straumann 
     Nobel Biocare 
 
 
0.15±0.31 mm,  
0.35± 0.43 mm 
Mean radiographic bone level from the implant 
collar to the bone at time of the 2nd stage surgery 
     Straumann 
     Nobel Biocare 
 
 
0.30± 0.36 mm,  
0.95± 1.3 mm 
Table 9: Demographic data, baseline and at 2nd stage surgery. 
 
The total sample size was 23 implants, 11 Straumann and 12 implants were Nobel 
Biocare. Five implants failed during the course of the study 3 Straumann and 2 Nobel 
Biocare. These implants were excluded from the statistical analysis.  The mean age of the 
patients was 56 years old for Straumann and 51.9 for Nobel Biocare implant subjects. 
Sixty-one percent (61%) of the total sample size were female. Twenty-three percent of 
the implants were placed in the maxillary molars area while 35% were in placed 
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mandibular molars. The remaining 42% were placed in the premolar area of the upper 
and lower jaw. The mean clinical bone level (MCBL) at time of implant placement was 
0.25 ± 0.23 mm, 0.55 ± 0.41 mm, and at time of 2nd stage surgery was 0.53 ± 0.4 mm, 1.2 
± 0.5 mm, for both Straumann and Nobel Biocare respectively. In contrast, the mean 
radiographic bone level (MRBL) at time of implant placement was 0.15±0.31 mm, 0.35± 
0.43 mm and at time of 2nd stage surgery was 0.30± 0.36 mm, 0.95± 1.3 mm for both 
Straumann and Nobel Biocare respectively. The outcome of interest for this study was the 
change in bone level between the time of implant placement and the 2nd stage surgery 
which was 0.14± 0.20 mm, and 0.72± 1.02 mm for Straumann and Nobel Biocare 
respectively in clinical measurement. The mean changes in radiographic bone loss for 
Straumann and Nobel Biocare were 0.23 ± 0.26 mm and 0.53± 1.06 mm.  Despite the 
clinical difference in the mean bone loss between the two systems (Straumann Bone 
Level and Nobel Biocare Replace) it did not reach statistical significance in either the 
clinical measurements (p=0.143) or the radiographic measurements (p=0.413). Due to the 
high variability in both of these measurements a bigger sample size may be required to 
reveal statistical significance. 
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DISCUSSION  
 Maintainence of peri-implant bone level in the preliminary stages of 
osseointegration is necessary for long-term implant stability and healthy peri-implant 
tissues. Marginal bone loss around implants reported in literature has been associated 
with different mechanical and biological causes. Our study concentrated and showed 
differences in the biological aspect between two implant systems. The mean clinical bone 
loss was 0.72 ± 1.02 for Nobel Biocare and 0.14 ± 0.20 mm for Straumann implants at 
the time of 2nd stage surgery. These levels were within limits of internationally accepted 
success criteria. Individual implant success rate was calculated instead of total implant 
success rate, since calculations based on the latter can hide critical clinical information 
when multiple implants are present in the same patient (Van de Velde, Collaert et al. 
2010). In our study most of the subjects had only one implant. To this date (2017), there 
have been no published studies associating early bone remodeling between the time of 
fixture insertion and connection of the prosthesis as described by Åstrand and co-workers 
(Astrand, Engquist et al. 2004).  
 
Attempts to standardize conditions for reproducible radiographic images have been 
problematic. The methodology utilized for the radiographic assessment of crestal bone 
loss in our study used elastomeric impression material to index an XCP film holder. 
Other studies have claimed that using the XCP without an index was a valid method to 
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detect bone loss (Bragger, Hafeli et al. 1998, Blanes, Bernard et al. 2007). In our study, 
we noticed variation in the images, which could affect the measurements (Fig 12-13,p 
34). This might have been caused by the index not being properly seated, or the patient 
might have accidentally chewed on the flexible material, or the XCP cone was not being 
properly angulated.  Using a special holding device attached directly to the implant to 
stabilize the sensor may be more precise (Naffah and Chidiac 2004). In summary the 
observed variation in radiographic images suggest that our clinical measures were a more 
valid description of the bone changes which took place. 
 
The Straumann Bone Level and Nobel Biocare Replace implants used in this study are 
both solid screw titanium implants but have different surface texture, thread and neck 
design, and use different surgical techniques. Both were installed in a two-step surgical 
procedure but theses variables were not evaluated.  
Early exposure of the cover screw during time of submerged healing has been associated 
with increased bone loss (Van Assche, Collaert et al. 2008). In the present study no 
exposure of cover screws was noted during healing.  
 
We did observe a pattern of marginal bone loss that varied between implant systems. In 
the Straumann implant bone loss tended to be a crater defect, dropping uniformly from 
the coronal edge vertically to apical edge of the collar (Fig 11,p33). In contrast, Nobel 
Biocare Replace implants displayed circumferential loss which was not as deep and 
extended more on the buccal side (Fig 10, p33).  
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The original Replace Implant was introduced by the Steri-Oss company (Yorbalinda, CA, 
USA) in 1998 and was sprayed with two surface treatments a rough titanium-plasma 
sprayed or hydroxyapatite coating. In 1999 Steri-Oss merged with Nobel Biocare AB 
(Gothenburg, Sweden), after which the implant became available with an oxidized 
surface (TiUnite). Few studies have been published that include radiographic analyses 
with Nobel Biocare Replace implants (Calandriello and Tomatis 2005, Mura 2012). Most 
studies have measured bone loss from placement to loading. In our current study we 
confined our observations to a shorter period (from the implant placement to 2nd stage 
surgery). For example Petterson et al reported Nobel Biocare implants had a mean 
radiographic bone loss of 0.9 ± 1.6 mm after one year of function with 1.5 mm lost during 
the first year (Pettersson and Sennerby 2015). In our study the mean radiographic bone 
loss for was 0.53 ± 1.06 mm. Straumann implant studies have shown (Blanes, Bernard et 
al. 2007, Akoglu, Ucankale et al. 2011, Hammerle, Jung et al. 2012) that the mean 
radiographic bone loss from the time of placement to prosthetic loading ranged between 
0.13 to 0.32 mm in 6 months period, while our results for the Straumann implant showed 
a mean bone loss of 0.23 ± 0.26 mm which is comparable. 
 
 
The connection between implant and abutment related to bone proximity may be a factor 
influencing bone resorption around the implant, although there is no conclusive evidence 
in the literature. Many studies have reported that moving the metal connection from the 
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edge of the implant towards its center (called the platform switch concept) can reduce the 
risk of early peri-implant bone resorption. This platform switch can be accomplished by 
using an abutment that is narrower than the implant platform or having an internal cone 
attachment like the Straumann design (van der Meij, Blankestijn et al. 2005, Hurzeler, 
Fickl et al. 2007, Rodriguez-Ciurana, Vela-Nebot et al. 2009, Atieh, Ibrahim et al. 2010, 
Wagenberg and Froum 2010). The measurements of bone loss with the platform switch 
concept are only available from after the 2nd stage surgery or later. The platform switch 
concept is implicit in Straumann implant design and we expect this might explain the 
difference in early bone loss between Straumann Bone Level implants compared to Nobel 
Biocare Replace implants. 
 
Conclusion: Within the limitation of this study including sample size, Nobel Biocare 
Replace tapered implants showed a two to five times higher average bone loss in 
radiographic and clinical parameters respectively, compared to Straumann implants. This 
difference did not reach statistical significance in either the radiographic measurement 
(p=0.413) or the clinical measurement (p=0.143). Measurement made on the buccal side 
of both implants at time of placement (Table 1 and 3) suggest that the implant buccal 
margins were systematically placed about 1 mm above the buccal bone margin (8 out of 
11 Straumann and 10 out of 12 Nobel) rather than on the same level of the bone. Thus we 
might consider developing techniques to avoid starting with a defect. Future studies 
should increase sample size, include other implant systems and develop a more 
reproducible radiographic index. 
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Figure 4: Straumann Bone Level implant, Arrow shows start point for the clinical 
measurement at the implant collar.  
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Figure 5: Nobel Biocare Replace tapered implant, Arrow shows start point of the clinical 
measurement at the implant collar.  
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Figure 6: Straumann Bone Level implant peri-apical radiograph at time of the implant 
placement 
 
 
 
 
Figure 7: Straumann Bone Level implant peri-apical radiograph at time of 2nd stage 
surgery. 
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Figure 8: Nobel Biocare Replace tapered peri-apical radiograph at time of the implant 
placement. 
 
 
 
				
Figure 9: Nobel Biocare Replace tapered peri-apical radiograph at time of 2nd stage 
surgery. 	
	33		
 
 
Figure 10: Nobel Biocare implant showed circumferential bone loss at time of 
uncovering 	
	
 
Figure 11: Straumann Bone Level implant showed buccal bone loss at time of 
uncovering 	
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Figure 12: Straumann Bone Level implant peri-apical radiograph at time of placement. 	
		
Figure 13: Straumann Bone Level Implant Peri-Apical Radiograph at time of 2nd stage 
surgery.  
*Note change in shape restoration to left of implant these images are not standardized 
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• Attendance of 5th  Riyadh International Dental Conferences. (December 15-16, 2010) 
• Attendance and organizing in " 22
nd Saudi Dental Society International Dental Conference” 
(January 24-26, 2011). 
• Attendance of: State of the Art of dental composite and SDR workshop (January 25, 2011). 
• Attendance of " AEEDC Conference" (Feb 1-3, 2011). 
• Attendance of "21 century Endodontic " lecture  (February 28, 2011). 
• Attendance and organizing in 23rd. Saudi Dental Society International Dental Conference. 
(February 6-8, 2012) 
• Organizer in " Growth Factor" workshop ( December 21, 2012)  
• Presenter at 24th Saudi Dental Society International Dental Conference. (28-30 Jan 2013) 
• Attendance of ITI study club Riyadh, Saudi Arabia (September 18,2012). 
• Attendance of ITI Residents Program at Tufts University (November 7th, 2015). 
• Presenter presentation at AADR 2016 USA (March 19, 2016) 
• Poster presentation in Science day 2016 at Boston University (March 23, 2016). 
• Poster presentation in tri-school meeting at Boston University (April 2nd, 2016).
 
 
Community 
Activities 
 
 
 
 
 
 
 
EXTRA 
CURRICULAR 
ACTIVITIES 
 
 
 
 
 
 
 
Special skills
	 
• Organizer and member of " As Pearl 2" Oral health community project. (October 2011) 
• Participate in community program for intermediate school about smoking cessation. 
• (2011)  
• Organizer and member of "Let us keep on it 2 " Oral health community program. (April 
2011) 
 
 
 
• Attendance of " Talented Meeting " held in King Saud University for 1 month. (July 2005) 
• Attendance of " Personality Styles" lectures. (17march 2010) 
• Attendance of " Life Management" lecture with 5hours training. (20March 2010) 
• Attendance of " Emotional Intelligence" lectures with 5 hours training. (30 March 2010) 
• Attendance of " Aims power" lecture with 5 hours training. (18 May 2010) 
• Attendance of "How to Know people personality" with 5 hours training. (1 June 2010) 
• General English Course with Upper Intermediate level in Language international in NEW 
ZEALAND.  (10 JULY- 27 Aug 2010) 
 
 
 
• Worked as organizer for self-improvement lectures and workshops in many institutes. 
• Lecturer in communication skills and Time management. 
	 53	
 
 
RESEARCH 
EXPERIENCE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARDS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publications 
 
 
 
 
 
 
 
 
 
 
 
Professional 
Membership 
•   
•  
•  
•  
•  
•  
•  
 
• Worked on research titled " The Changes in the Level of Matrix Metalloproteinases-8 
(MMP-8) in the Crevicular Fluids around Implants as a Predictor for Peri-
implantitis in Healthy individuals : A Systematic Review  
• Leader of the group which planned and conducted  research project titled : “ Evaluation 
Of  Patient Satisfaction and Esthetic Outcome for Maxillary Anterior Single-tooth 
Implants “ sent for publication. 
• Working on research project titled” Influence of Gingival Display on Smile 
Attractiveness in Saudi Laypersons and Dental Professionals” 
• Presentation of "Evaluation Of Patient Satisfaction and Esthetic Outcome for 
Maxillary Anterior Single-tooth Implants" in two international conferences. 
• Presentation of "Retrospective Review Of Early Bone Loss: Comparison Of Three 
Different Implant Systems" in two conferences. 
• Working on master thesis " Early Bone Loss: Comparison Of Three Different 
Implant Systems, Prospective clinical study" 
 
 
• Award of writing skills among Riyadh high school students. (2005) 
• Second Award for Poster Presentation of " Evaluation Of Patient Satisfaction and 
Esthetic Outcome for Maxillary Anterior Single-tooth Implant " in the 24th Saudi 
Dental Society International Dental Conference" held in Riyadh  (28-30 Jan 2013). 
• First Award for Poster Presentation of " Evaluation Of Patient Satisfaction and Esthetic 
Outcome for Maxillary Anterior Single-tooth Implant " in 10th Makkah International 
Dental Conference & 9th Gulf Dental Association Conference held in Makkah (2-4 April 
2013) 
 
 
• AlMoharib HS, AlMubarak A, AlRowis R, Geevarghese A, Preethanath RS, Anil S. 
Oral fluid based biomarkers in periodontal disease: part 1. Saliva. J Int Oral Health. 
2014 Jul;6(4):95-103.  
• AlRowis R, AlMoharib HS, AlMubarak A, Bhaskardoss J, Preethanath RS, Anil S. Oral 
Fluid-Based Biomarkers in Periodontal Disease – Part 2. Gingival Crevicular Fluid. 
J Int Oral Health. 2014 Sep-Oct; 6(5): 126–135. 
• Anil S, Alrowis R, Chalisserry P, Chalissery V, AlMoharib H, AlSulaimani A. Oral 
Health and Adverse Pregnancy Outcomes- Chapter in Emerging Trend in Oral health 
sciences and Dentistry book Published March 2015. 
 
• Member of Osseointegration research chair in college of dentistry (2011-2012). 
• Member of Dental Student 's Social and Cultural Committees (2008-2011). 
• Member of Saudi Dental Society (2008-present). 
• Students' Rights in the college of dentistry (2009). 
• Accreditation committee in College of Dentistry (2011). 
• Charitable Society For Orphans Care (2011). 
• Member of American Academy of Periodontology (2014- present). 
• ITI member (2016-present). 
